Evaluation of the Effect of Eltrombopag on the Expression of Platelet Collagen Receptor Glycoprotein VI (GPVI) in Pediatric Patients With Chronic and Persistent Immune Thrombocytopenia
Latest Information Update: 29 Oct 2021
At a glance
- Drugs Eltrombopag (Primary) ; Azathioprine; Mycophenolate mofetil; Rituximab
- Indications Idiopathic thrombocytopenic purpura
- Focus Pharmacodynamics
- 26 Oct 2021 Status changed from recruiting to completed.
- 07 Jul 2020 Planned End Date changed from 1 Nov 2019 to 1 Dec 2020.
- 07 Jul 2020 Planned primary completion date changed from 1 Nov 2019 to 1 Sep 2020.